6 documents found, page 1 of 1
Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal implant: ...
Carneiro, Angela; Meireles, Angelina; Castro Sousa, João Paulo; Teixeira, CarlaIntroduction: The ILUVIEN® (fluocinolone acetonide) Clinical Evidence in Portugal (ICE-PT) study is a retrospective, multicenter, observational study evaluating the effectiveness and safety of the FAc implant in patients with diabetic macular edema. Methods: Patients included in this study had received the 0.2 µg/day fluocinolone acetonide implant for the treatment of diabetic macular edema and had measurements...
Editorial
Rocha-Sousa, Amândio; Carneiro, Angela; Silva, Rufino
Degenerescência Macular da Idade (DMI) - Guidelines de Tratamento 2018
Teixeira, Carla C; Furtado, Maria João; Carneiro, Angela; Silva, RufinoDegenerescência Macular da Idade (DMI) - Guidelines de Tratamento 2018
Therapeutic itineraries for patients with cerebrovascular accident: fragmentati...
Fausto, Márcia Cristina Rodrigues; Campos, Estela Márcia Saraiva; Almeida, Patty Fidelis; Medina, Maria Guadalupe; Giovanella, Ligia; Bousquat, Aylene-; Objectives: to analyze the itineraries of patients with cerebrovascular accident (CVA) in the Interstate health region in San Francisco Valley. Methods: this study uses the qualitative approach through the construction of Therapeutic Itineraries (IT). In the IT mapping the observation was prioritized on the different points and forms to access health service in search of care.. Results: sixteen semi-structur...
A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patient...
Silva, Rufino; Goncalves, Carla; Meireles, Angela; Teixeira, Carla; Rosa, Paulo; Monteiro-Grillo, Manuel; Canelas, Joaquim; Carneiro, AngelaIntroduction: Anti-vascular endothelial growth factor therapy has revolutionized the treatment of wet age-related macular degeneration; however, it is important to monitor actual use of ranibizumab and related treatment outcomes in routine practice. Material and Methods: This was a retrospective, observational study to monitor the 2-year outcomes following ranibizumab treatment for wet age-related macular degen...
A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patient...
Silva, Rufino; Goncalves, Carla; Meireles, Angela; Teixeira, Carla; Rosa, Paulo; Monteiro-Grillo, Manuel; Canelas, Joaquim; Carneiro, AngelaIntroduction: Anti-vascular endothelial growth factor therapy has revolutionized the treatment of wet age-related macular degeneration; however, it is important to monitor actual use of ranibizumab and related treatment outcomes in routine practice.Material and Methods: This was a retrospective, observational study to monitor the 2-year outcomes following ranibizumab treatment for wet age-related macular degene...